My primary clinical and research area of interest is plasma cell dyscrasias, such as multiple myeloma and AL amyloidosis. I am focused on clinical trials designed to improve the standard of care of patients with these disorders. In addition to clinical trials, I have an informatics background, which I leverage by applying clinically relevant questions to real-world evidence.
Partial Data by Infogroup (c) 2024. All rights reserved.